XU MEDICAL AS
2318 HAMAR
Return on Equity
152,62Â %
Current Ratio
1,26
Debt-to-Equity Ratio
0,31
Key figures (NOK) | 2022 | |
---|---|---|
Revenue | 6Â 568Â 000 | |
Net Income | 1Â 459Â 000 | |
Total Assets | 5Â 093Â 000 | |
Total Equity | 956Â 000 |
Income (NOK) | 2022 | |
---|---|---|
Revenue | 6Â 568Â 000 | |
Expenditure | 4Â 687Â 000 | |
Operating Profit | 1Â 881Â 000 | |
Financial Income | 1Â 000 | |
Financial Costs | 12Â 000 | |
Financial Balance | −11 000 | |
Earnings Before Tax | 1Â 870Â 000 | |
Tax | 411Â 000 | |
Net Income | 1Â 459Â 000 |
Balance (NOK) | 2022 | |
---|---|---|
Total Fixed Assets | 266Â 000 | |
Total Current Assets | 4Â 827Â 000 | |
Total Assets | 5Â 093Â 000 | |
Total Retained Equity | 856Â 000 | |
Total Equity | 956Â 000 | |
Total Long-Term Debt | 300Â 000 | |
Total Current Debt | 3Â 836Â 000 | |
Total Equity and Debt | 5Â 093Â 000 |
Cash flow (NOK) | 2022 | |
---|---|---|
Sales Income | 1Â 454Â 000 | |
Other Income | 5Â 114Â 000 | |
Revenue | 6Â 568Â 000 | |
Cost of Goods Sold | 0 | |
Salary Costs | 2Â 646Â 000 | |
Depreciation | 11Â 000 | |
Impairment | 0 | |
Expenditure | 4Â 687Â 000 | |
Operating Profit | 1Â 881Â 000 | |
Financial Income | 1Â 000 | |
Financial Costs | 12Â 000 | |
Financial Balance | −11 000 | |
Dividends | 3Â 090Â 000 | |
Net Income | 1Â 459Â 000 |
Balance details (NOK) | 2022 | |
---|---|---|
Goodwill | 0 | |
Total Intangible Assets | 0 | |
Real Eastate | 0 | |
Machinery and Plant Facilities | 0 | |
Fixtures | 24Â 000 | |
Total Tangible Assets | 24Â 000 | |
Total Fiancial Fixed Assets | 242Â 000 | |
Total Fixed Assets | 266Â 000 | |
Stock | 0 | |
Total Investments | 0 | |
Cash, Bank | 127Â 000 | |
Total Current Assets | 4Â 827Â 000 | |
Total Assets | 5Â 093Â 000 | |
Total Equity | 956Â 000 | |
Short-Term Group Debt | 0 | |
Total Long-Term Debt | 300Â 000 | |
Creditors | 6Â 000 | |
Unpaid Taxes | 159Â 000 | |
Dividends | 3Â 090Â 000 | |
Other Current Debt | 171Â 000 | |
Total Current Debt | 3Â 836Â 000 | |
Total Equity and Debt | 5Â 093Â 000 |
Financial indicators | 2022 | |
---|---|---|
Return on Equity | 152,62Â % | |
Debt-to-Equity Ratio | 0,31 | |
Operating Profit Margin | 28,64Â % | |
Current Ratio | 1,26 | |
Quick Ratio | 1,26 | |
Equity Ratio | 0,19 | |
Gross Profit Margin | 100Â % |
Rotate your device to see the full table